Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada
INTRODUCTION: Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2012/583630 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849308359623180288 |
|---|---|
| author | Amir A Tahami Monfared Amy K O’Sullivan Coleman Rotstein George Papadopoulos |
| author_facet | Amir A Tahami Monfared Amy K O’Sullivan Coleman Rotstein George Papadopoulos |
| author_sort | Amir A Tahami Monfared |
| collection | DOAJ |
| description | INTRODUCTION: Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective. |
| format | Article |
| id | doaj-art-0f4e49d9cb5147faa4328000452e848b |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-0f4e49d9cb5147faa4328000452e848b2025-08-20T03:54:29ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322012-01-01232596410.1155/2012/583630Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in CanadaAmir A Tahami Monfared0Amy K O’Sullivan1Coleman Rotstein2George Papadopoulos3Merck & Co Inc, Kirkland, Quebec, Canadai3 Innovus, Medford, Massachusetts, USAUniversity of Toronto, University Health Network, Toronto, Ontario, CanadaMerck & Co Inc, Whitehouse Station, New Jersey, USAINTRODUCTION: Posaconazole prophylaxis in high-risk neutropenic patients prevents invasive fungal infection (IFI). An economic model was used to assess the cost effectiveness of posaconazole from a Canadian health care system perspective.http://dx.doi.org/10.1155/2012/583630 |
| spellingShingle | Amir A Tahami Monfared Amy K O’Sullivan Coleman Rotstein George Papadopoulos Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada |
| title_full | Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada |
| title_fullStr | Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada |
| title_full_unstemmed | Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada |
| title_short | Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada |
| title_sort | economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in canada |
| url | http://dx.doi.org/10.1155/2012/583630 |
| work_keys_str_mv | AT amiratahamimonfared economicevaluationofposaconazoleversusstandardazoletherapyasprophylaxisagainstinvasivefungalinfectionsinpatientswithprolongedneutropeniaincanada AT amykosullivan economicevaluationofposaconazoleversusstandardazoletherapyasprophylaxisagainstinvasivefungalinfectionsinpatientswithprolongedneutropeniaincanada AT colemanrotstein economicevaluationofposaconazoleversusstandardazoletherapyasprophylaxisagainstinvasivefungalinfectionsinpatientswithprolongedneutropeniaincanada AT georgepapadopoulos economicevaluationofposaconazoleversusstandardazoletherapyasprophylaxisagainstinvasivefungalinfectionsinpatientswithprolongedneutropeniaincanada |